Changes in cognitive functioning with risperidone and olanzapine treatment: A large-scale, double-blind, randomized study

Psychopharmacology

Volumn 169, Issue 3-4, 2003, Pages 404-411

  Harvey, Philip D ^a   Green, Michael F ^b   McGurk, Susan R ^a   Meltzer, Herbert Y ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive functioning; Executive functioning; Learning; Memory; Olanzapine; Risperidone; Schizoaffective disorder; Schizophrenia

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LEARNING; LEARNING TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MOTOR DYSFUNCTION; MULTICENTER STUDY; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; TASK PERFORMANCE; UNITED STATES;

ADOLESCENT; ADULT; AROUSAL; BENZODIAZEPINES; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; MOVEMENT DISORDERS; PIRENZEPINE; PSYCHOMOTOR PERFORMANCE; RISPERIDONE; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; VERBAL LEARNING;

EID: 0141993537     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1342-5     Document Type: Article

References (28)

1. Buchanan RW, Holstein C, Breier A (1994) The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry 36:717-725
2. Cornblatt BA, Lenzenweger MF, Erlenmeyer-Kimling L (1989) The continuous performance test, identical pairs version. II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Res 29:65-85
3. Chouinard G, Ross-Chouinard A, Annable L, Jones B (1980) The extrapyramidal symptoms rating scale. Can J Neurol Sci 7:233
4. Delis DC, Kramer JH, Kaplan E, Ober BA (1987) The California verbal learning test: research edition. Psychological Corporation, San Antonio
5. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330
6. Green MF, Marshall BD Jr, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J (1997) Does risperidone improve verbal working memory in treatment resistant schizophrenia? Am J Psychiatry 154:799-804
7. Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff?" Schizophr Bull 26:119-136
8. Harvey PD (2000) Long term cognitive effects of risperidone in patients with schizophrenia or schizoaffective disorder. American Psychiatric Association Annual Meeting, Chicago
9. Harvey PD, Keefe RSE (2001) Studies of cognitive change with novel antipsychotic treatment. Am J Psychiatry 158:176-184
10. Heaton RK, Chelune CJ, Talley JL, Kay GG, Curtiss G (1993) Wisconsin card sorting test manual - revised and expanded. Psychological Assessment Resources, Odessa
11. Hegarty JD, Baldessarini RJ, Tohen M (1994) One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 151:1409-1416
12. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY (2002) Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26:325-339
13. Kay SR (1991) Positive and negative syndromes in schizophrenia. Brunner/Mazel, New York
14. Keefe RSE, Perkins S, Silva SM, Lieberman JA (1999) The effect of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 25:201-222
15. Kern RS, Green MF, Marshall BD Jr, Wirshing WC, Wirshing D, McGurk S, Marder SR, Mintz J (1999) Verbal learning in schizophrenia: effects of novel antipsychotic medication. Schizophr Bull 25:223-232
16. Kuroki T, Meltzer HY, Ichikawa J (1999) Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288:774-781
17. Lee MA, Thompson PA, Meltzer HY (1994) Effects of clozapine on cognitive function in schizophrenia. J Clin Psychiatry 55:82-87
18. Lee MA, Jayathilake K, Meltzer HY (1999) A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophr Res 37:1-11
19. Lezak MD (1997) Neuropsychological assessment, 3rd edn. Oxford University Press, New York
20. Medalia A, Gold J, Merriam A (1988) The effects of antipsychotics on neuropsychological test results of schizophrenics. Arch Clin Neuropsychology 3:249-271
21. Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233-255
22. Meltzer HY, Burnett S, Bastani B, Ramirez LF (1990) Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 41:892-897
23. Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A (2000) Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 57:249-258
24. Rossi A, Mancini F, Stratta P, Mattei P, Gismondi R, Pozzi F (1997) Risperidone, negative symptoms, and cognitive deficits in schizophrenia. An open study. Acta Psychiatr Scand 95:40-43
25. Sax KW, Strakowski SM, Keck PE Jr (1998) Attentional improvement following quetiapine fumarate treatment in schizophrenia. Schizophr Res 33:151-155
26. Serper MR, Chou JCY (1997) Novel neuroleptics improve attentional functioning in schizophrenic patients. CNS Spectrums 2:56-60
27. Spohn HE, Strauss ME (1989) Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 98:478-486
28. Spreen O, Strauss E (1998) A compendium of neuropsychological tests and norms, 2nd edn. Oxford University Press, New York